A Nationwide Drug Utilization Study Assessing Treatment Changes In All Registered Danish Atrial Fibrillation Patients Initiating Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Using Danish Registries
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 11 Apr 2017 New trial record